Dual association of serum interleukin-10 levels with colorectal cancer
Author(s) -
Shabnam Abtahi,
Forogh Davani,
Zahra Mojtahedi,
Seyed Vahid Hosseini,
Alimohammad Bananzadeh,
Abbas Ghaderi
Publication year - 2017
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.199448
Subject(s) - medicine , colorectal cancer , pathological , biomarker , pathogenesis , cytokine , gastroenterology , interleukin 10 , immune system , oncology , cancer , disease , interleukin , case control study , immunology , biology , biochemistry
Interleukin 10 (IL-10) is considered an immune modulator cytokine, showing both antitumor and pro-tumor characteristics. Its role in the pathogenesis and progression of colorectal cancer depends on microenvironmental milieu.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom